<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200429047244N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-02-02</date_registration>
      <primary_sponsor>University of Baghdad</primary_sponsor>
      <public_title>Using Cryotherapy, EMLA Cream, and Lidocaine Spray to Reduce Pain during Arteriovenous Fistula Puncture: A Randomized Clinical Trial</public_title>
      <acronym></acronym>
      <scientific_title>Comparison the effectiveness of Cryotherapy, EMLA Cream, and Lidocaine Spray to Reduce Pain during Arteriovenous Fistula Puncture among clients undergoing hemodialysis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-02-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>86</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/61456</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: A simple randomization sampling method will be used to assign the study sample in four groups: ice pack, EMLA cream, lidocaine spray, and a control group.  Simple randomization is an appropriate method to be used in this clinical trial to increase the probability and reduce and bias. A sealed envelope contained four colors (red, blue, green, and yellow) will be given to each client to choose one color. The clients were allocated to groups based on their colors; red= control, blue= ice pack, green= EMLA cream, and yellow= lidocaine spray. Indeed, four groups will be allocated randomly.</study_design>
      <phase>3</phase>
      <hc_freetext>Arteriovenous Fistula in End-stage Renal Failure.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group1:  5 cubs of ice (4 × 2 × 2 cm) will be placed in a plastic bag and covered with a layer of cotton cloth for five minutes on the site of AVF. Then, the area will be disinfected by 70% alcohol pads before the AVF puncture. After that, the needle will be inserted by the ward nurse, and the pain will be assessed immediately after the needle insertion. Intervention 2: Intervention group2: 1.5 g of EMLA cream (Lidocaine 25 mg and Prilocaine 25 mg, Recipharm Karlskoga) will be applied to six cm2 on the area of AVF for 20 minutes before the AVF puncture. After that, the EMLA cream will be removed, and the area will be disinfected by 70% alcohol pads. Then, the needle will be inserted by the ward nurse, and the pain will be assessed immediately after the needle insertion. Intervention 3: Intervention group3: three sprinklings of lidocaine spray (ElQady, Ankara, Turkey) will be sprayed on the AVF. After five minutes (Bhalla et al., 2009), the area will be disinfected by 70% alcohol pads. Then, the needle will be inserted by the ward nurse, and the pain will be assessed immediately after the needle insertion. Intervention 4: Control group: no procedures will be done before AVF puncture, and the pain will be assessed immediately after the needle insertion.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The data will be the results of Visual Analogue Scale that measure clients' pain during AVF puncture in both control and interventions groups.

When:
If the article is published in an open access journal, the data will be available after 6 months of publication. If the article is published in a subscribed journal, the data will be available after one year
because of the policy of the subscribed journals.

To whom:
With academic nurses and any researcher who is interested in the data

Conditions:
The data could be used after getting the authors' permission via email. Also, users need to acknowledge
the owner.

Where to obtain:
Users can ask for the data and the permission via email. Dr. Al-Jubouri is the corresponding
author. He will be in contact with whom ask for the data. His email is maaljubouri@conursing.uobaghdad.edu.iq Also, Dr. Al-Jubouri works at University of Baghdad/
College of Nursing. The address is Bab Al-Muadham, Baghdad, Iraq.

How to obtain:
Users can ask for the data and the permission via email. Dr. Al-Jubouri is the corresponding
author. He will be in contact with whom ask for the data. His email is
maaljubouri@conursing.uobaghdad.edu.iq

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammed Baqer Al-Jubouri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Al-Adhamia, Al-Keriaat</address>
        <city>Baghdad</city>
        <country1>Iraq</country1>
        <zip>10053</zip>
        <telephone>+964 1 489 6875</telephone>
        <email>maaljubouri@conursing.uobaghdad.edu.iq</email>
        <affiliation>University of Baghdad</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammed Baqer Al-Jubouri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Al-Adhamia, Al-Keriaat</address>
        <city>Baghdad</city>
        <country1>Iraq</country1>
        <zip>10053</zip>
        <telephone>+964 1 489 6875</telephone>
        <email>maaljubouri@conursing.uobaghdad.edu.iq</email>
        <affiliation>University of Baghdad</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iraq</country2>
      <country2>Iraq</country2>
      <country2>Iraq</country2>
      <country2>Iraq</country2>
      <country2>Iraq</country2>
      <country2>Iraq</country2>
      <country2>Iraq</country2>
    </countries>
    <criteria>
      <inclusion_criteria>clients with more than 18 years old
being under hemodialysis at least for three months
being conscious and alert
be able to sign the written informed consent</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>clients who are cold intolerance
clients who have allergy from local anesthetics or topical medications
Clients who have upper extremities paralysis
pregnant or lactating females</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I28.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Arteriovenous fistula of pulmonary vessels</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group1:  5 cubs of ice (4 × 2 × 2 cm) will be placed in a plastic bag and covered with a layer of cotton cloth for five minutes on the site of AVF. Then, the area will be disinfected by 70% alcohol pads before the AVF puncture. After that, the needle will be inserted by the ward nurse, and the pain will be assessed immediately after the needle insertion.</i_keyword>
      <i_keyword>Intervention group2: 1.5 g of EMLA cream (Lidocaine 25 mg and Prilocaine 25 mg, Recipharm Karlskoga) will be applied to six cm2 on the area of AVF for 20 minutes before the AVF puncture. After that, the EMLA cream will be removed, and the area will be disinfected by 70% alcohol pads. Then, the needle will be inserted by the ward nurse, and the pain will be assessed immediately after the needle insertion.</i_keyword>
      <i_keyword>Intervention group3: three sprinklings of lidocaine spray (ElQady, Ankara, Turkey) will be sprayed on the AVF. After five minutes (Bhalla et al., 2009), the area will be disinfected by 70% alcohol pads. Then, the needle will be inserted by the ward nurse, and the pain will be assessed immediately after the needle insertion.</i_keyword>
      <i_keyword>Control group: no procedures will be done before AVF puncture, and the pain will be assessed immediately after the needle insertion.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain during arteriovenous fistula puncture in clients undergoing hemodialysis. Timepoint: Immediately after the arteriovenous fistula puncture. Method of measurement: Visual Analogue Scale is a measurement tool that will be used to assess clients' pain.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>The author himself is the funding source.</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-01-23</approval_date>
        <contact_name>Ethics committee in College of Nursing at University of Baghdad</contact_name>
        <contact_address>Bab-AlMuadham Baghdad Baghdad Iraq</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
